King; Bryan W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for King; Bryan W..The latest application filed is for "heterocyclic amides as kinase inhibitors".

Company Profile

4.7.15

King; Bryan W. - Collegeville PA
KING; Bryan W. - King of Prussia PA
King; Bryan W. - Blue Bell PA
King; Bryan W. - Wilmington DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modulators of stimulator of interferon genes (STING) Grant 11,377,440 - Fosbenner , et al. July 5, 2	2022-07-05
Heterocyclic Amides as Kinase Inhibitors App 20210253532 - Anderson; Niall Andrew ; et al.	2021-08-19
Heterocyclic amides as kinase inhibitors Grant 10,899,716 - Anderson , et al. January 26, 2	2021-01-26
Modulators Of Stimulator Of Interferon Genes (sting) App 20200291001 - FOSBENNER; David T. ; et al.	2020-09-17
Heterocyclic Amides As Kinase Inhibitors App 20200165205 - ANDERSON; Niall Andrew ; et al.	2020-05-28
Heterocyclic amides as kinase inhibitors Grant 10,590,085 - Anderson , et al.	2020-03-17
Heterocyclic Amides As Kinase Inhibitors App 20180134665 - ANDERSON; Niall Andrew ; et al.	2018-05-17
Enhancer Of Zeste Homolog 2 Inhibitors App 20160122342 - FOSBENNER; David T. ; et al.	2016-05-05
Amino-quinolines As Kinase Inhibitors App 20160060222 - BURY; Michael Jonathan ; et al.	2016-03-03
Amino-quinolines As Kinase Inhibitors App 20130053375 - Bury; Michael Jonathan ; et al.	2013-02-28
Imidazolyl-imidazoles As Kinase Inhibitors App 20130018039 - Bodmer; Vera Q. ; et al.	2013-01-17
Lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme Grant 7,122,560 - King October 17, 2	2006-10-17
Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme Grant 7,074,810 - King , et al. July 11, 2	2006-07-11
Cyclic sulfonyl compounds as inhibitors of metalloproteases Grant 6,927,216 - Cherney , et al. August 9, 2	2005-08-09
Lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme App 20040266751 - King, Bryan W.	2004-12-30
Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme App 20040116491 - King, Bryan W. ; et al.	2004-06-17
Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha App 20040072802 - Duan, Jingwu ; et al.	2004-04-15
.beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. Grant 6,495,565 - Duan , et al. December 17, 2	2002-12-17
Cyclic sulfonyl compounds as inhibitors of metalloproteases App 20020086853 - Cherney, Robert J. ; et al.	2002-07-04
Beta-Amino-Acid derivatives as inhibitors of matrix metalloproteases and TNF-Alpha App 20020013341 - Duan, Jingwu ; et al.	2002-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.